Section R156-17b-610 - Operating Standards - Patient CounselingUnder Subsection 58-17b-601(1), guidelines for providing patient counseling in Section 58-17b-613 include the following:
(1)(a) Counseling shall be offered orally in person, unless the patient or patient's agent is not at the pharmacy or a specific communication barrier prohibits oral communication.(b) Counseling may be provided through a telepharmacy system.(2) A pharmacy facility shall orally offer to counsel, but is not required to counsel a patient or patient's agent who refuses counseling.(3) Based upon the professional judgment of the pharmacist, pharmacy intern, or DMP, patient counseling may include the following elements: (a) name and description of the prescription drug;(b) dosage form, dose, route of administration and duration of drug therapy;(c) intended use of the drug, when known, and expected action;(d) special directions and precautions for preparation, administration and use by the patient;(e) common severe side or adverse effects or interactions and therapeutic contraindications that may be encountered, including their avoidance, and the action required if they occur;(f) techniques for self-monitoring drug therapy;(h) prescription refill information;(i) action to be taken in the event of a missed dose;(j) pharmacist comments relevant to the individual's drug therapy, including any other information specific to the patient or drug; and(k) the date after which the prescription should not be taken or used, or the beyond use date.(4) The offer to counsel shall be documented. Documentation shall be maintained for five years, and be available for inspection by the Division within seven to ten business days of the Division's request.(5) Only a pharmacist, pharmacy intern, or DMP may orally provide counseling to a patient or patient's agent and answer questions concerning prescription drugs.(6) If a prescription drug order is delivered to the patient or patient's agent or other designated location: (a) the information in Subsection (3) shall be delivered with the dispensed prescription in writing;(b) if prescriptions are routinely delivered outside the area covered by the pharmacy's local telephone service, the pharmacist shall place on the prescription container or on a separate sheet delivered with the prescription container, the telephone number of the pharmacy and the statement "Written information about this prescription has been provided for you. Please read this information before you take this medication. If you have questions concerning this prescription, a pharmacist is available during normal business hours to answer these questions."; and(c) the written information under Subsection (6)(b) shall be in the form of patient information leaflets similar to USP-NF patient information monographs or equivalent information.(7) Patient counseling is not required for patients of a hospital or institution where other licensed health care professionals are authorized to administer the patient's drugs.(8) A pharmacist or pharmacy intern who dispenses a self-administered hormonal contraceptive shall obtain a completed Utah Hormonal Contraceptive Self-Screening Risk Assessment Questionnaire and provide written information and counseling as described in Section 26-62-106.Utah Admin. Code R156-17b-610
Amended by Utah State Bulletin Number 2015-6, effective 2/24/2015Amended by Utah State Bulletin Number 2019-2, effective 12/27/2018Amended by Utah State Bulletin Number 2019-24, effective 11/25/2019Amended by Utah State Bulletin Number 2023-02, effective 1/5/2023